Not all patients who share a certain organ involvement can be treated with the same medicine at the same dose. In this piece, Foundation Medical Director Dr. Joan Merrill argues that improved classification of lupus can lead to better treatment.
Off-label drugs for the treatment of lupus symptoms represents the standard of care for people with lupus, but current regulations make it difficult for doctors and manufacturers to communicate. Read Sandra C. Raymond's remarks now.
August 2015 - Dr. Donald Thomas answered your 15 questions about lupus diagnosis.
Further studies may lead to interventions that improve the health outcomes of people with lupus.
In honor of National Friendship Day, we’re sharing some of your advice on how friends could better support people with lupus in maintaining a social life.
Results from a study of epratuzumab were released today. It did not meet its primary endpoint of clinically reducing the severity of lupus in people with mild to moderate disease. The following is a statement from Sandra C. Raymond, President and CEO
Attorney by day, romance novelist by night, Chloe Barlow found her inspiration to write after struggling with the realities of chronic illness. Read her story now!
Today, the U.S. House of Representatives passed the 21st Century Cures Act, legislation that has the potential to improve the drug development process and bring new and vital treatments forward for people with chronic diseases like lupus.